Total Funding
43
Total FundingVenture - Series Unknown raised
Growth Score in past quarter
pts
Heat Score 43 in past quarter
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Bioharmony Therapeutics is developing next-gen antimicrobial therapies for lethal multi-drug resistant bacterial infections.
- Chandrabali Ghose: Founder and CEO
About the Company
Developer of first-in-class lysin-based antimicrobial therapeutics. The company's antimicrobial therapeutics offers a treatment for skin infections caused by multi-drug resistant acinetobacter baumanii.
Women Founded